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Summary
Duane retraction syndrome (DRS) is a congenital eye-
movement disorder characterized by a failure of cranial
nerve VI (the abducens nerve) to develop normally, re-
sulting in restriction or absence of abduction, restricted
adduction, and narrowing of the palpebral fissure and
retraction of the globe on attempted adduction. DRS
has a prevalence of ∼0.1% in the general population
and accounts for 5% of all strabismus cases. Undiagno-
sed DRS in children can lead to amblyopia, a permanent
uncorrectable loss of vision. A large family with auto-
somal dominant DRS was examined and tested for ge-
netic linkage. After exclusion of candidate regions pre-
viously associated with DRS, a genomewide search with
highly polymorphic microsatellite markers was per-
formed, and significant evidence for linkage was ob-
tained at chromosome 2q31 (D2S2314 maximum LOD
score 11.73 at maximum recombination fraction .0).
Haplotype analysis places the affected gene in a 17.8-
cM region between the markers D2S2330 and D2S364.
No recombinants were seen with markers between these
two loci. The linked region contains the homeobox D
gene cluster. Three of the genes within this cluster,
known to participate in hindbrain development, were
sequenced in affected and control individuals. Coding
sequences for these genes were normal or had genetic
alterations unlikely to be responsible for the DRS phe-
notype. Identifying the gene responsible for DRS may
lead to an improved understanding of early cranial-nerve
development.
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Introduction
Duane retraction syndrome (DRS [MIM 126800]) is a
congenital disorder of eye movement (Duane 1905), in
which patients exhibit partial or complete failure of ab-
duction and partial closure of the eyelids, with retraction
of the globe into the orbit on adduction (fig. 1). DRS is
a frequent cause of strabismus in children andmay result
in amblyopia-related visual loss. Although this syndrome
can be unilateral and sporadic, many familial cases have
been reported; these are usually bilateral and inherited
in an autosomal-dominant fashion (Sevel and Kassar
1974).
Electromyographic (Huber 1974) data suggest that
DRS may result from abnormal development or absence
of the abducens nerve (cranial nerve VI). Analysis of
autopsy specimens revealed the absence of the abducens
nuclei in both unilateral and bilateral cases of DRS
(Hotchkiss et al. 1980; Miller et al. 1982). The absence
of the left abducens nerve in an individual with unilateral
DRS was established by use of magnetic-resonance im-
aging (Parsa et al. 1998).
DRS can be associated with other nonocular anom-
alies, such as Klippel-Feil anomaly, Wildervank syn-
drome, Goldenhar syndrome (Pfaffenbach et al. 1972),
Rubinstein-Taybi syndrome (Cruz et al. 1995), and Bat-
ten disease (Marshman et al. 1998). Three karyotypic
abnormalities, associated with chromosomes 4, 8, and
22, have been found in patients with DRS; however, all
three cases exhibited other ocular and nonocular prob-
lems. A de novo deletion of a region of chromosome 4
(4q27–31) was observed in a 15-year-old boy with bi-
lateral blepharoptosis, DRS, and “mild learning diffi-
culties” (Chew et al. 1995). An insertion/deletion event
resulting in both the deletion of chromosome region
8q12–13 and the insertion of this segment into 6q25
was noted in a patient with DRS, mental retardation,
and other anatomic malformations (Calabrese et al.
1998). Cytogenetic analysis of two siblings manifesting
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Figure 1 Photodocumentation of a patient with DRS, exhibiting
incomplete abduction on attempted right or left gaze.
DRS, bilateral sensorineural deafness, unilateral renal
agenesis, and preauricular skin tags indicated the pres-
ence of a supernumerary bisatellited marker chromo-
some derived from chromosome 22pter-q11 (Cullen et
al. 1993).
In the present study, we describe a large four-gener-
ation family from Oaxaca, Mexico, with 25 living mem-
bers affected with DRS transmitted in a fully penetrant
autosomal-dominant pattern. Chromosomal loci previ-
ously associated with DRS were excluded by genetic
linkage analysis (Ott et al. 1999). A genomewide search
was undertaken to identify the locus responsible for this
form of DRS.
Subjects and Methods
Clinical Evaluations
After informed consent was obtained, ophthalmic,
neurological, and surgical histories were studied. All liv-
ing family members (with the exception of individuals
II-4, II-8, and III-17) were examined, and peripheral
blood was drawn for direct genomic DNA isolation or
transformation of B-lymphoblasts. All subjects were
tested for visual acuity, ocular ductions and versions,
ocular alignment by prism-cover testing, fixation pref-
erence, and globe retraction. Determination of the
Duane phenotype was made by one examiner (M.S.B.),
on the basis of limitation of abduction in one or both
eyes, incomitant strabismus, and lid fissure narrowing
on adduction of affected eyes. For a more detailed de-
scription of the clinical diagnosis performed, see Chung
et al. (in press). Patients with a history of strabismus
surgery who did not meet the above diagnostic criteria
were considered to be of indeterminate status and were
considered unknown in subsequent linkage analysis.
Studies were performed in accordance with a protocol
approved by the Committee on Clinical Investigations
of Childrens Hospital Los Angeles
Genotyping and Linkage Analysis
Genotyping was performed by use of 396 fluorescent
dye–labeled dinucleotide-repeat markers (Prism Linkage
Mapping Set version 2; PE Biosystems). The PCR con-
ditions employed are given in detail at the PE Biosystems
database. The PCR products were electrophoresed in 48-
lane, 5% denaturing polyacrylamide gels in ABI 377
sequencers. The GENESCAN and GENOTYPER soft-
ware packages (PE Biosystems) were used to generate
genotypes. Parametric two-point and multipoint LOD-
score analyses were performed by use of FASTLINK (La-
throp et al. 1984). The genetic model assumed dominant
inheritance with penetrance equal to .99. On the basis
of the prevalence of DRS in the population (DeRespinis
et al. 1993), a phenocopy rate of .001 was assumed. In
regions showing significant evidence of linkage, lower
penetrances, of .9 and .8, were also tested. Only one
disease liability was considered. For the genome scan,
allele frequencies were estimated on the basis of data on
the founders of the pedigree.
Fine Mapping and Haplotype Analysis
After evidence for linkage was obtained at 2q31, pan-
els of additional dye-labeled markers were designed.
Haplotype analysis, using D2S2333, D2S2216,
D2S160, D2S347, D2S112, D2S2313, D2S142,
D2S2330, D2S335, D2S364, D2S117, D2S325,
D2S2382, D2S126, D2S396, D2S206 and D2S125
(ABI-PRISM Linkage Mapping Set) and D2S333,
D2S1238, D2S2314, D2S1244, D2S1245, homeobox D
(HOXD), and D2S138, which span the interval between
D2S2330 and D2S364 (Genetic Location Database),
was performed to identify the markers flanking the dis-
ease region. Genotyping was performed as described
above, and haplotypes were constructed by use of
GENEHUNTER 2.0 (Kruglyak et al. 1996).
Sequence Analysis of Candidate Homeobox Genes
PCR primers flanking each of the coding exons of the
human genes HOX D3 (GenBank accession number,
D11117) and D4 (GenBank accession number, X17360)
and D1 (cloned during this study) were used to amplify
and sequence these genetic segments in affected and con-
trol subjects. PCR reactions contained 50–100 ng of ge-
nomic DNA, 20 pmol of each primer, 0.5 U of Pfu poly-
merase (Stratagene), 4 mM of each dNTP and 5 ml of a
10# cloned Pfu buffer in a total reaction volume of 50
ml. PCR reactions were optimized on a Robocylcer Gra-
dient 96 (Stratagene); conditions typically were 96C for
5 min, followed by 30 cycles of 95C for 1 min,
56C–68C for 1 min, and 72C for 1 min. For difficult
templates, such as exon 1 of D1, 4% dimethyl sulfoxide
was added to the PCR reaction mix before amplification.
PCR products were electrophoresed through 1.5% aga-
rose and were purified by use of a QIAquick gel ex-
traction kit (Qiagen) prior to direct cycle sequencing.
Sequencing was performed on an automated ABI 310
sequencer by use of dye-terminator chemistry and the
manufacturer’s protocols (Applied Biosystems). The
structure and sequence of the human HOX D1 gene was
determined (data not shown). A human bacterial arti-
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Figure 2 Pedigree of the large DRS family used for linkage analysis. All individuals, with the exception of the deceased and individuals
(denoted by a minus sign []), were examined for DRS. DNA was prepared from subjects and was genotyped for linkage analysis. Individuals
denoted with a plus sign () were used to confine the critical disease region (see fig. 5). Individual III-16 was phenotypically classified as
“indeterminate.”
ficial chromosome (BAC) library was screened by PCR,
by use of primers designed to the second exon and 3′
UTR of the HOX D3 gene, to isolate a clone containing
the adjacent HOX D1 (situated 3′ to HOX D3). On the
basis of the mouse homologue, primers were designed
to amplify HOX D1 coding segments from the positive
BAC, to obtain the corresponding human sequence. The
products were sequenced, and the remainder of theHOX
D1 coding region was obtained by sequencing the BAC
directly. HOX D1 exons were amplified and sequenced
as described above.
Results
The family consists of 118 members, spanning four
generations, of which 24 individuals, after clinical ex-
amination, were definitively diagnosed with DRS (fig.
2). All living affected individuals have limited abduction,
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Table 1
Two-Point LOD Scores
CHROMOSOME
2 MARKER
TWO-POINT LOD SCORE AT v =a
.0 .05 .1 .2 .3 .4
D2S112 22.75 4.29 1.55 .5 .94 .58
D2S2313 29.31 5.94 2.75 .11 .62 .45
D2S142 7.58 1.24 .12 .68 .79 .54
D2S2330 3.53 6.79 6.87 5.92 4.32 2.25
D2S333 9.05 8.37 7.63 6.00 4.15 2.06
D2S335 4.9 4.53 4.14 3.27 2.26 1.13
D2S1238 7.54 6.95 6.34 5.0 3.48 1.74
D2S2314 11.73 10.87 9.96 7.92 5.58 2.88
D2S1244 10.82 10.04 9.20 7.31 5.15 2.64
D2S1245 6.3 5.83 5.32 4.19 2.9 1.4
HOXD13 1.38 1.17 .96 .55 .24 .03
D2S138 11.11 10.29 9.40 4.19 2.90 1.40
D2S364 8.79 6.19 6.33 5.50 4.04 2.11
D2S117 16.77 2.11 3.03 3.12 2.31 1.08
D2S325 19.05 1.40 2.79 3.31 2.72 1.5
a Calculated under the assumption of an autosomal-dominant, fully
penetrant genetic model (penetrance .99) with a phenocopy rate of
.001.
Figure 3 Graph of multipoint LOD scores, between DRS and
chromosome 2 markers D2S142, D2S333, D2S335, D2S1238,
D2S2314, D2S1244, D2S1245, HOXD13, and D2S138, for the large
Mexican family.
with narrowing of the palpebral fissure and retraction
of the globe on adduction. Some individuals showed
limited adduction (Chung et al., in press). Individual III-
16 was orthotropic; however, she had a history of stra-
bismus surgery for esotropia noted at an early age and
so was considered to be “indeterminate” for the pur-
poses of analysis (fig. 2). No apparent nonocular asso-
ciated dysmorphism was observed (Chung et al., in
press). Before a genomewide search was performed, can-
didate chromosome loci were tested for linkage. Twenty-
four microsatellite markers were typed for chromosomes
4, 8, and 22, and all are associated with LOD scores
!.5 (Ott et al. 1999).
Linkage and Haplotype Analysis
The genomewide screen with highly polymorphic
markers spaced at ∼10-cM intervals revealed linkage
only at 2q31. Maximum two-point LOD scores of 6.9
( ), 4.9 ( ), and 6.3 ( ) were seen at markersv = .1 v = 0 v = .1
D2S2330, D2S335, and D2S364, respectively. A maxi-
mum two-point LOD score of 11.73 ( ) was sub-v = 0
sequently observed with marker D2S2314, and a max-
imum multipoint LOD score of 12.69 centering on
marker D2S2314 was obtained. Microsatellite markers
yielding significant LOD scores are presented in table 1,
and the multipoint linkage analyses are presented in fig-
ure 3.
Haplotype analysis has refined the region to a 17.8-
cM interval situated between D2S2330 and D2S364 (fig.
4). GENEHUNTER predicted a common haplotype,
comprising the markers D2S333, D2S335, D2S1238,
D2S2314, D2S1244, D2S1245, HOXD13, andD2S138,
which segregate with all individuals diagnosed with the
DRS phenotype. The proximal flanking marker
D2S2330 and the distal flanking marker D2S364 are
defined by recombination events within individuals III-
30 and III-8/III-22, respectively (fig. 5). Individual III-
16, who was originally classified as “indeterminate” be-
cause of a history of strabismus surgery, also carried the
common “disease-associated” haplotype, indicating that
this person is affected. Thus, although only 24 individ-
uals were clinically diagnosed with DRS, we feel both
that it is likely that individual III-16 is affected and that
her strabismus surgery corrected a DRS-related
esotropia.
Sequence Analysis of Candidate Homeobox Genes
Sequencing of the coding regions of the HOXD1, D3,
and D4 genes from patients with DRS in this particular
family presented no changes that were indicative of a
functional disruption of an expressed protein. A ho-
mozygous nucleotide change, GrC, was observed in
exon 1 of the D3 gene (position 1745; GenBank acces-
sion number D11117) which would result in an amino
change of a cysteine (codon TGT) to a serine (codon
TCT), in both affected and normal individuals (data not
shown). This TCT codon is also seen within an alter-
native HOX D3 sequence submitted to the database
(EMBL accession number Y09980), suggesting that this
cysteine-to-serine substitution is a polymorphism that
occurs without consequence in the general population.
A heterozygous genotype (T/C) in exon 2 of D3 at
position 4270 (GenBank accession number D11117),
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Figure 4 Schematic representation of the genetic map of the
region containing the DRS locus. The flanking proximal and distal
markers, separated by 17.8 cM, are shown in boldface. The distances
(in cM) between the markers D2S160, D2S112, D2S142, D2S2330,
D2S333, D2S364, D2S117, D2S382, and D2S396 are underlined. The
order of and the genetic distances between markers were obtained
from the PE Biosystems ABI PRISM mapping Web page.
segregated with the affected individuals, whereas the ho-
mozygous genotype, C/C, was present in all the unaf-
fected individuals (data not shown). Although this re-
sults in a change of a codon from CTG to TTG (codon
335), both of these codons code for the amino acid leu-
cine; thus, the primary protein sequence of HOX D3 is
the same on both of the chromosomes from the affected
individuals.
Discussion
This study provides strong evidence for linkage of an
autosomal-dominant form of DRS to 2q31. Chromo-
somal localization of DRS is the initial step toward the
isolation and functional characterization of the gene/
protein responsible for this phenotype and should in-
crease our understanding of cranial-nerve development.
It should be noted that DRS may be genetically heter-
ogeneous. As mentioned earlier, there is evidence that
suggests that additional loci associated with DRS map
to chromosomes 4, 8, and 22.
Electromyographic data (Sato 1960; Huber 1974) and
postmortem histopathologic data attribute the DRS phe-
notype to the abnormal development of the abducens
nerve nuclei. The association of other congenital ana-
tomic malformations with DRS has led some to suggest
that the dysgenesis event occurs sometime between the
4th and 10th wk of gestation (Cross and Pfaffenbach
1972). Functional characterization of the DRS gene will
help us understand the physiology and mechanism of
cranial-nerve embryogenesis.
There are a number of candidate genes, known to be
expressed during embryogenesis, within this disease in-
terval, including the genes within the HOXD cluster.
HOX genes are developmental control genes that reg-
ulate morphogenesis and cell differentiation in animals,
and the expression of HOX genes can be detected as
early as gastrulation in mammals (Mark et al. 1997).
In humans there are four HOX gene clusters—HOXA,
-B, -C, and -D—situated on chromosomes 7, 17, 12, and
2, respectively. The spatial pattern of HOX-gene ex-
pression in the developing embryo is directly related to
the chromosomal order of the genes within the cluster.
Genes at the 5′-most end of the HOX cluster have the
most posterior (caudal) boundary of expression, and
each successive gene 3′ is progressively expressed in
more-anterior (rostral) regions (Dubuole and Dolle´
1989; Giampaolo et al. 1989; Graham et al. 1989;
Guant 1991). The 3′-most genes within the HOXD clus-
ter are D1, D3, and D4. Embryonic-gene-expression
studies and gene knockout data in mouse homologues
of the human D1, D3, and D4 and their paralogue genes
( A1, B1, A3, B3, A4, B4, and C4) indicate that these
genes are necessary for the normal development of the
head, the hindbrain, and associated structures (Frohman
et al. 1990; Hunt et al. 1991; Frohman andMartin 1992;
Carpenter et al. 1993; Dolle´ et al. 1993; Bedford et al.
1995; Manley and Capecchi 1997). Interestingly, dis-
ruption of the mouse Hoxb1 gene resulted in failure of
the motor nucleus of the facial (VIIth) nerve to develop
(Goddard et al. 1996). Thus, genes that are expressed
early in embryogenesis and that are involved in the de-
velopment of the hindbrain are strong candidates for
DRS.
The fact that the HOX D1, D3, and D4 genes fit the
above criteria prompted us to amplify and sequence
these genes from individuals in the family studied. Al-
though no coding-sequence mutations likely to cause the
disease phenotype were found within the HOX genes
analyzed in this study, we are continuing our efforts to
search for causative mutations outside the coding se-
quence of these genes.
The expression of HOX genes is known to be regu-
lated by retinoids: vitamin A derivatives, usually all-
trans- and 9-cis-retinoic acid (RA [Simeone et al. 1991;
Moroni et al. 1993]). Enhancers containing RA response
Figure 5 Haplotypes for chromosome 2 markers, for a subset of the large Mexican family with DRS. The order of the DNA markers is shown. The disease-associated alleles are boxed. The
critical interval lies between markers D2S2330 and D2S364 and is indicated by the arrows. Two other markers, D2S335 and D2S1244 (not shown), are also within this critical interval.
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elements (RARE), which are responsible for the RA-reg-
ulated expression, are found within 3′ regions of the
mouse Hoxa1 and Hoxb1 genes (Langston et al. 1997)
and within both the 3′ and 5′ regions of the mouse
Hoxd4 gene (Zhang et al. 1997). A conserved RARE
was found associated with the chick and mouse and
Hoxb1 genes that acts to restrict expression to a specific
segment (rhombomere 4) of the normal developing hind-
brain (Studer et al. 1994). It is interesting to note that
in vivo disruption of the mouse Hoxa1 3′ RARE results
in cranial-nerve and hindbrain abnormalities similar to
the phenotypes of the Hoxa1 knockouts (Dupe et al.
1997). Abnormal development of the VIIth–XIth cranial
nerves can occur as a result of disruption of the 3′ RARE
of the Hoxa1 and Hoxb1 genes (Gavalas et al. 1998).
It is possible that disruption of regulatory elements as-
sociated with the humanHOX genes within theD cluster
may result in DRS. With this in mind we are character-
izing the 3′ and 5′ regions of the HOX D1, D3, and D4
genes in affected individuals of this large family.
As far as we are aware, this is the first linkage data
for a family with an autosomal dominant form of DRS
without other associated dysmorphisms. Characteriza-
tion of other families with DRS may permit refinement
of the critical region.Manymouse homeobox genes have
been targeted for disruption of normal function; howeve,
none to date exhibit a phenotype that is reminiscent of
DRS. Considering the phenotype of the mouse Hoxb1
knockout, which fails to develop a normal VIIth-nerve
motor nucleus (Goddard et al. 1996), it would be of
great interest to know the phenotype of a Hoxd1-defi-
cient mouse. Isolation and functional analysis of the gene
responsible for DRS will give us a new insight into the
intricate processes involved in the early development of
the hindbrain and cranial nerves. Assignment of this new
locus for nonsyndromic DRS is a significant advance
toward identification of the genetic basis of this
condition.
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